000 | 01715 a2200493 4500 | ||
---|---|---|---|
005 | 20250516015756.0 | ||
264 | 0 | _c20110928 | |
008 | 201109s 0 0 ger d | ||
022 | _a1432-055X | ||
024 | 7 |
_a10.1007/s00101-010-1819-2 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSchmidt, T | |
245 | 0 | 0 |
_a[Thrombotic microangiopathy after extracorporeal circulation: important differential diagnosis]. _h[electronic resource] |
260 |
_bDer Anaesthesist _cMay 2011 |
||
300 |
_a451-6 p. _bdigital |
||
500 | _aPublication Type: Case Reports; Journal Article | ||
650 | 0 | 4 |
_aADAM Proteins _xgenetics |
650 | 0 | 4 | _aADAMTS13 Protein |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 |
_aAortic Diseases _xcomplications |
650 | 0 | 4 |
_aAspirin _xtherapeutic use |
650 | 0 | 4 |
_aComa _xetiology |
650 | 0 | 4 | _aCritical Care |
650 | 0 | 4 | _aDiagnosis, Differential |
650 | 0 | 4 |
_aExtracorporeal Circulation _xadverse effects |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aHemolytic-Uremic Syndrome _xetiology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aMitral Valve Insufficiency _xcomplications |
650 | 0 | 4 |
_aPeripheral Vascular Diseases _xdiagnosis |
650 | 0 | 4 |
_aPlatelet Aggregation Inhibitors _xtherapeutic use |
650 | 0 | 4 |
_aPostoperative Complications _xgenetics |
650 | 0 | 4 |
_aPurpura, Thrombocytopenic _xetiology |
650 | 0 | 4 | _aRisk Factors |
650 | 0 | 4 |
_aThrombosis _xetiology |
650 | 0 | 4 |
_avon Willebrand Factor _xgenetics |
700 | 1 | _aTsakiris, D A | |
700 | 1 | _aGrapow, M | |
700 | 1 | _aSiegemund, M | |
773 | 0 |
_tDer Anaesthesist _gvol. 60 _gno. 5 _gp. 451-6 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00101-010-1819-2 _zAvailable from publisher's website |
999 |
_c20471377 _d20471377 |